tradingkey.logo
tradingkey.logo
Search

Acrivon Therapeutics Inc

ACRV
Add to Watchlist
1.500USD
-0.020-1.32%
Close 07-31 16:00ETQuotes delayed by 15 min
58.12MMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
RA Capital Management, LP
28.57%
Chione, Ltd.
8.99%
Sands Capital Ventures LLC
4.96%
Blume-Jensen (Peter)
4.86%
Citadel Advisors LLC
3.84%
Other
48.78%
Shareholders
Shareholders
Proportion
RA Capital Management, LP
28.57%
Chione, Ltd.
8.99%
Sands Capital Ventures LLC
4.96%
Blume-Jensen (Peter)
4.86%
Citadel Advisors LLC
3.84%
Other
48.78%
Shareholder Types
Shareholders
Proportion
Venture Capital
28.62%
Hedge Fund
13.42%
Corporation
8.99%
Individual Investor
5.98%
Investment Advisor/Hedge Fund
5.53%
Investment Advisor
3.73%
Research Firm
1.31%
Other
32.41%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
141
18.50M
45.25%
-3.29M
2025Q4
134
17.71M
69.32%
+182.87K
2025Q3
137
17.53M
70.68%
-320.02K
2025Q2
135
17.85M
68.05%
-1.81M
2025Q1
131
22.63M
79.77%
-2.38M
2024Q4
129
23.33M
79.05%
+324.92K
2024Q3
114
23.28M
78.63%
-499.83K
2024Q2
109
23.78M
71.37%
+2.33M
2024Q1
99
15.56M
68.24%
+116.36K
2023Q4
85
15.61M
68.75%
+202.59K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
RA Capital Management, LP
8.34M
21.53%
--
--
Mar 19, 2026
Chione, Ltd.
3.85M
9.93%
--
--
Jun 30, 2024
Sands Capital Ventures LLC
2.12M
5.48%
--
--
Dec 31, 2025
Blume-Jensen (Peter)
2.15M
5.55%
-14.27K
-0.66%
Feb 21, 2026
Citadel Advisors LLC
1.64M
4.24%
-79.98K
-4.65%
Dec 31, 2025
Two Sigma Investments, LP
918.84K
2.37%
+463.14K
+101.63%
Dec 31, 2025
Wellington Management Company, LLP
888.13K
2.29%
--
--
Dec 31, 2025
Acadian Asset Management LLC
581.21K
1.5%
+489.20K
+531.72%
Dec 31, 2025
Renaissance Technologies LLC
634.17K
1.64%
+10.77K
+1.73%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco Nasdaq Biotechnology ETF
0.01%
ProShares Ultra Nasdaq Biotechnology
0.01%
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
iShares Biotechnology ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
Proshares Ultra Russell 2000
0%
Schwab U.S. Broad Market ETF
0%
View more
Invesco Nasdaq Biotechnology ETF
Proportion0.01%
ProShares Ultra Nasdaq Biotechnology
Proportion0.01%
iShares Micro-Cap ETF
Proportion0.01%
iShares Russell 2000 Value ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
iShares Biotechnology ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
Schwab U.S. Broad Market ETF
Proportion0%
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.